SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-006291
Filing Date
2018-05-09
Accepted
2018-05-08 17:42:43
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 AERI 3.31.201810-Q aerie33118.htm 10-Q 647390
2 AERI 3.31.2018 EX 10.1 aeri3312018ex101.htm EX-10.1 98173
3 AERI 3.31.2018 EX 31.1 aeri3312018ex311.htm EX-31.1 16408
4 AERI 3.31.2018 EX 31.2 aeri3312018ex312.htm EX-31.2 16505
5 AERI 3.31.2018 EX 32.1 aeri3312018ex321.htm EX-32.1 10033
6 AERI 3.31.2018 EX 32.2 aeri3312018ex322.htm EX-32.2 9975
  Complete submission text file 0001628280-18-006291.txt   4225628

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aeri-20180331.xml EX-101.INS 810003
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20180331.xsd EX-101.SCH 36545
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20180331_cal.xml EX-101.CAL 52307
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20180331_def.xml EX-101.DEF 156994
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20180331_lab.xml EX-101.LAB 469924
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20180331_pre.xml EX-101.PRE 273082
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 18816037
SIC: 2836 Biological Products, (No Diagnostic Substances)